Extended Input Deadline for USP´s new Chapter on Quality Considerations for Cannabis
Register now for ECA's GMP Newsletter
Following the previously announced elaboration of a new USP chapter <1568> Quality Considerations for Cannabis and Cannabis-derived Products for Clinical Research the input deadline has been extended to 31 July 2022.
USP is requesting early input from stakeholders on the proposed new General Chapter <1568> which is then expected to be published for comment in Pharmacopeial Forum.
More Information is available at the USP Compendial Notices Website.
Related GMP News
01.07.2025GMP non-Compliance Reports for two Cannabis Sites
01.07.2025New Ph. Eur. Chapter for Estragole Determination
01.07.2025EMA Reflection Paper on Data Recommendations for Herbal Medicinal Products
20.05.2025Update on the USP CBD Monograph
20.05.2025Proposed USP Quality Attributes for Cannabis in Clinical Investigations
02.04.2025BfArM Guideline for the Application for a Licence to Cultivate Cannabis